Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
This study is completed in the United States. It is testing Abuse Potential of EB-1020 Immediate-Release for ADHD.
In Overland Park
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Abuse Potential of EB-1020 Immediate-Release for ADHD.
In Overland ParkThis study is completed in the United States. It focuses on Addiction.
Multiple locations, including LexingtonThis study is completed in the United States. It is testing Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia.
Multiple locations, including GlendaleThis study is completed in Austria, in Germany, in Spain, .... It is testing Effect of ALKS 3831 Compared to Olanzapine on Body Weight for schizophrenia.
In AustriaThis study was terminated in Taiwan. It is testing Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function for schizophrenia.
Multiple locations, including Bali Township, Taipei CountyThis study was terminated in Germany. It is testing effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and for Bipolarity.
In GöttingenThis study is completed. It is testing Effectiveness and Safety of 3 Doses of Paliperidone Palmitate for schizophrenia.
Location not clearly listedThis study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.
Multiple locations, including ScottsdaleThis study is completed in China, in Malaysia, in South Korea, .... It is testing effectiveness and Safety of Paliperidone Palmitate for schizophrenia.
Multiple locations, including HuzhouThis study is completed in the Netherlands. It is testing Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving for depression.
In LeidenThis study is completed in the United States. It is testing effects of Basmisanil for schizophrenia.
Multiple locations, including Little RockThis study is completed in the United States. It is testing Effects of Once Daily Doses of AQW051 on Cognition, for schizophrenia.
Multiple locations, including Garden GroveHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.